<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03988062</url>
  </required_header>
  <id_info>
    <org_study_id>CRD1003</org_study_id>
    <nct_id>NCT03988062</nct_id>
  </id_info>
  <brief_title>Aneurysm Packing With the Expandable TrelliX Coil System - A Prospective Safety Study</brief_title>
  <acronym>APEX-FIH</acronym>
  <official_title>Aneurysm Packing With the Expandable TrelliX Coil System - A Prospective Safety Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shape Memory Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shape Memory Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      APEX-FIH is a first-in-human, open-label prospective multicenter study of the TrelliX Embolic&#xD;
      Coil System for use in embolization of the medium to large, ruptured or unruptured cerebral&#xD;
      aneurysms&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 21, 2018</start_date>
  <completion_date type="Anticipated">July 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety - Serious adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of freedom from incidence of serious adverse events related to the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy - Angiographic occlusion</measure>
    <time_frame>Immediate</time_frame>
    <description>Rate of angiographic occlusion based on Raymond-Ray grading scale [1 No filling of aneurysm neck or dome; 2 Residual filling of aneurysm neck, not dome; 3 Residual filling of aneurysm neck and dome (worst outcome)]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy - Angiographic occlusion</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Rate of angiographic occlusion based on Raymond-Ray grading scale [1 No filling of aneurysm neck or dome; 2 Residual filling of aneurysm neck, not dome; 3 Residual filling of aneurysm neck and dome (worst outcome)]</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ruptured or Unruptured Cerebral Aneurysms</condition>
  <arm_group>
    <arm_group_label>TrelliX Embolic Coil System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TrelliX Embolic Coil System</intervention_name>
    <description>Embolic coil with shape memory polymer</description>
    <arm_group_label>TrelliX Embolic Coil System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject age ≥18 and ≤80 years with a diagnosis of a ruptured or unruptured&#xD;
             intracranial aneurysm judged suitable for selective endovascular treatment by coil&#xD;
             occlusion during single procedure&#xD;
&#xD;
          -  Aneurysm size [largest measurement from the cross sectional images to determine&#xD;
             overall aneurysm size, not just the lumen) ≥5 mm and ≤16mm&#xD;
&#xD;
          -  If ruptured aneurysm: either WFNS grade 1 or 2, or Hunt and Hess 1 or 2&#xD;
&#xD;
          -  If unruptured aneurysm: Subject grade Modified Rankin Scale mRS 0 - 2&#xD;
&#xD;
          -  Investigator plans to use ≥70% in volume TrelliX coils to fill target aneurysm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior treatment (surgical or endovascular) of the target aneurysm&#xD;
&#xD;
          -  Planned treatment of multiple aneurysms in index procedure&#xD;
&#xD;
          -  Planned use of other modified coils (Matrix, HydroCoil or fibered coils)&#xD;
&#xD;
          -  Planned use of liquid embolic material&#xD;
&#xD;
          -  Life expectancy less than 12 months&#xD;
&#xD;
          -  Presence of arteriovenous malformation&#xD;
&#xD;
          -  Fusiform, mycotic, traumatic, or tumoral aneurysms&#xD;
&#xD;
          -  Intended or planned aneurysm treatment by parent vessel occlusion&#xD;
&#xD;
          -  Clipping or endovascular treatment of another intracranial aneurysm performed within&#xD;
             30 days before or planned within 30 days following the index procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clínico Regional Guillermo Grant Benavente</name>
      <address>
        <city>Concepción</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Parra</last_name>
      <phone>+56 41 2723077</phone>
      <email>jparra@ssconcepcion.cl</email>
    </contact>
    <investigator>
      <last_name>Pablo Giacaman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Einersen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto de Neurocirugía</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loreto Bravo</last_name>
      <phone>+ 56 2 2575 4843</phone>
      <email>loreto.bravo@redsalud.gov.cl</email>
    </contact>
    <investigator>
      <last_name>Daniel Echeverría, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rodrigo Rivera, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Sordo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2019</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

